China Insulin Delivery Devices Market Size & Outlook
China insulin delivery devices market, 2018-2030 (US$M)
Related Markets
China insulin delivery devices market highlights
- The China insulin delivery devices market generated a revenue of USD 617.5 million in 2023 and is expected to reach USD 1,171.9 million by 2030.
- The China market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, insulin pens was the largest revenue generating product in 2023.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Insulin delivery devices market data book summary
| Market revenue in 2023 | USD 617.5 million |
| Market revenue in 2030 | USD 1,171.9 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Insulin pens |
| Fastest growing segment | Insulin Pumps |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes |
| Key market players worldwide | Novo Nordisk A/S ADR, Sanofi SA, Eli Lilly and Co, Ypsomed Holding AG, Medtronic PLC, Abbott Laboratories, Roche, Biocon, Wockhardt |
Other key industry trends
- In terms of revenue, China accounted for 3.8% of the global insulin delivery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan insulin delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,171.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Delivery Devices Market Scope
Insulin Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China insulin delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin delivery devices market will help companies and investors design strategic landscapes.
Insulin pens was the largest segment with a revenue share of 43.03% in 2023. Horizon Databook has segmented the China insulin delivery devices market based on insulin pens, insulin pumps, insulin pen needles, insulin syringes covering the revenue growth of each sub-segment from 2018 to 2030.
It is estimated that approximately one in ten individuals in China have diabetes, making it difficult to determine the exact number of cases due to several going undetected. China has now become the country with the highest diabetic population in the world, surpassing India.
Diabetes is most prevalent due to urbanization, improved standards of living, and an aging population. To reduce medical expenses for diabetic and high blood pressure patients, the National Health Commission of China has started reimbursing outpatients for over half of their medication costs.
In addition, more hospitals in China are planning to establish National Metabolic Management Centers (MMC) to explore a new model of diabetes treatment. These MMCs have already provided services to over 200,000 patients in the last 2 years, as reported by China’s National Health Commission statistics.
Reasons to subscribe to China insulin delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China insulin delivery devices market databook
-
Our clientele includes a mix of insulin delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China insulin delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into China insulin delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China insulin delivery devices market size, by insulin pens, 2018-2030 (US$M)
China Insulin Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
